EyePoint Pharmaceuticals Inc (STU:PV3B)
€ 7.012 0.01 (0.14%) Market Cap: 382.82 Mil Enterprise Value: 152.78 Mil PE Ratio: 0 PB Ratio: 1.83 GF Score: 59/100

EyePoint Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript

Jun 7, 2023 / 06:30 PM GMT
Release Date Price: €5.9 (+7.27%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EYPT.OQ - EyePoint Pharmaceuticals Inc
EyePoint Pharmaceuticals Inc at Jefferies Healthcare Conference
Jun 07, 2023 / 06:30PM GMT

=====================
Conference Call Participants
=====================
* George O. Elston
EyePoint Pharmaceuticals, Inc - Chief Financial Officer

=====================
Presentation
--------------------------------------------------------------------------------
George O. Elston, EyePoint Pharmaceuticals, Inc - Chief Financial Officer [1]
--------------------------------------------------------------------------------
Good afternoon, everyone. My name is George O Elston. I'm the CFO of EyePoint Pharmaceuticals and thank you for joining us today to hear a little bit about the EyePoint story. First, we'd like to thank Jefferies for this opportunity to be in front of you today. And I think you'll like what you hear about what's been going on at a point up.

First and foremost, we may be making forward-looking statements today, and I'll refer you to our SEC filings that are on
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot